Table 4.
Ref. | n | Age | Male:female | Cirrhosis/ hepatitis | AFP elevated | Median size (cm) | > 1 tumor | Positive node | Vascular invasion | Initial operation | Repeat operation | Median f/u | 5 yr survival | Prognostic factor |
Hemming et al[18], 1997 | 10 | 31 | 50:50 | NR | 10% | 8 | 20% | 20% | NR | Phx 100% | 50% | 101 | 70% | NR |
El-Gazzaz et al[19], 2000 | 20 | 27 | 65:35 | 0% hep B | 0% | 14 | 20% | 30% | 55% | Phx 55% OLT 45% | NR | 25 | 50% | NONE |
Kakar et al[20], 2005 | 20 | 27 | 53:27 | 0% | 3/13 (23%) | < 10 31% ≥ 10 69% | 10% | 35% | NR | Phx 100% | NR | NR | 62% | Metastasis at presentation |
Stipa et al[21], 2006 | 28 | 28 | 43:57 | 0% | 7% | 9 | 11% | 50% | 36% | Phx 100% | 61% | 34 | 76% | Positive LN |
Present study | 22 | 29 | 50:50 | 9%/hepc | 9% | 12 | 13% | 18% | 23% | Phx 100% | 18% | 42 | 65% | Vascular invasiom |
Hep: Hepatitis; AFP: Alpha-fetoprotein elevated (> 200 ng/mL); Phx: Partial hepatectomy; NR: Not reported; f/u: Follow up.